Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin pharmacokinetics in pleural empyema and complicated parapneumonic effusion
NL-OMON49528Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amoxicillin and clavulanic acid in Empyema Thoracis and parapneumonic effusion (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Probability of target attainment in pleural fluid. Started Jun 2020; status: completed.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
Empyema Thoracisparapneumonic effusion
Beyond the preview
Go deeper on NL-OMON49528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49528.